In an effort to improve outcomes for patients with some of the deadliest childhood cancers, St. Jude Children’s Research Hospital scientists have created the world’s largest collection of pediatric solid tumor samples, drug-sensitivity data and related information and have made the resource available at no charge to the global scientific community.
St. Jude and the Howard Hughes Medical Institute collaborated to create the resource, known as the Childhood Solid Tumor Network. The work is reported today as an advance online publication in the scientific journal Nature.
“Survival rates for children with recurrent solid tumors have not improved significantly in more than 20 years and remain below 30 percent,” said corresponding author Michael Dyer, Ph.D., chair of the St. Jude Department of Developmental Neurobiology and a Howard Hughes Medical Institute investigator. “This research will change that by promoting scientific collaboration to leverage the efforts of researchers worldwide to advance understanding and ultimately treatment of pediatric solid tumors.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8121952-st-jude-childrens-childhood-solid-tumor-network/
St. Jude Children’s Research Hospital® officials and guests today marked the opening of the St. Jude Red Frog Events Proton Therapy Center, the first proton therapy center in the world dedicated solely to children with cancer.
Patients are now being treated at the center using precisely delivered, high-energy particles called protons to kill or shrink tumors while minimizing damage to healthy tissue and organs. For patients with brain tumors and certain other cancers, research suggests proton beam therapy may be more effective than conventional radiation at preventing the growth and spread of tumors while reducing the risk of treatment-related side effects.
To view the multimedia release go to:
http://www.multivu.com/players/English/7713451-st-jude-proton-therapy-opening/
Inspired by Ole Henriksen’s passion for helping people, OLEHENRIKSEN introduces a limited-edition Luxury-size Truth Serum for Holiday 2017 in partnership with Starlight Children’s Foundation, a 501 (c)(3) organization whose mission is to bring joy and comfort to hospitalized children and their families. For every OLEHENRIKSEN Luxury-size Truth Serum sold, the brand will donate 10% of the proceeds to the Starlight Brave Gowns Program, which replaces unattractive and uncomfortable hospital garments with high-quality, comfortable and brightly colored gowns.
Starlight Brave Gowns transform children into astronauts, cowboys and other characters, empowering them to have fun and enjoy being kids during their hospital stays, especially during the holiday season. Best of all, OLEHENRIKSEN has also designed a bright and colorful child-friendly hospital Starlight Brave Gown, and the sale of each Luxury-size Truth Serum will help in gifting these gowns and the Ole Glow® to the Starlight Children’s Foundation.
To view the multimedia release go to:
https://www.multivu.com/players/English/8215851-olehenriksen-partners-with-starlight-childrens-foundation/
Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options.
In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe.
To view the multimedia release go to:
http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
St. Catherine Hospital from Croatia has been named as one of the finalists, and Ruban d’Honneur recipients, in the 2016/17 European Business Awards sponsored by RSM.
It is one of only 110 finalists announced after over 33,000 businesses were engaged in the competition, and was chosen by a panel of independent judges because it displayed the core values of innovation, ethics and success.
The company will now undertake an in depth face-to-face interview, and will find out if it is a winner of one of the 11 categories at a Gala Final on May 4 in Dubrovnik.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8037951-st-catherine-hospital-business-awards/
When a life-changing diagnosis brings moments of uneasiness, a glimmer of hope can make all the difference in bringing solace. As hope comes in many forms, Extended Stay America® hotels, the nation’s largest owner operated hotelier, announced today the launch of the brand’s latest initiative in their continued support for the fight against cancer – the “Give Hope” program. A natural evolution of Extended Stay America’s partnership with the American Cancer Society, the “Give Hope” program provides a platform to raise awareness and funds for pediatric cancer research.
To view the multimedia release go to:
https://www.multivu.com/players/English/8060751-extended-stay-america-give-hope-cancer-research/
